Total Payments
$3,990
2024 Payments
$275.00
Companies
12
Transactions
54
Medicare Patients
2,107
Medicare Billing
$137,726
Payment Breakdown by Category
Food & Beverage$3,426 (85.8%)
Other$500.00 (12.5%)
Education$64.69 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,426 | 48 | 85.8% |
| Honoraria | $500.00 | 1 | 12.5% |
| Education | $64.69 | 5 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,841 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $586.82 | 6 | $0 (2019) |
| Life Technologies Corporation | $500.00 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $296.09 | 6 | $0 (2018) |
| Amarin Pharma Inc. | $150.28 | 2 | $0 (2018) |
| Celgene Corporation | $134.62 | 1 | $0 (2017) |
| Lilly USA, LLC | $132.95 | 4 | $0 (2017) |
| Amgen Inc. | $114.58 | 1 | $0 (2018) |
| Medtronic MiniMed, Inc. | $90.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $89.04 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.00 | 2 | Gilead Sciences, Inc. ($275.00) |
| 2023 | $763.07 | 5 | Life Technologies Corporation ($500.00) |
| 2022 | $144.46 | 3 | Gilead Sciences, Inc. ($131.44) |
| 2021 | $100.00 | 1 | Gilead Sciences, Inc. ($100.00) |
| 2019 | $450.87 | 8 | Gilead Sciences, Inc. ($226.07) |
| 2018 | $828.51 | 13 | Gilead Sciences, Inc. ($333.30) |
| 2017 | $1,428 | 22 | Gilead Sciences Inc ($512.26) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: HBV | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 10/24/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.08 | General |
| 07/20/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 03/31/2023 | Life Technologies Corporation | — | Honoraria | Cash or cash equivalent | $500.00 | General |
| 03/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.99 | General |
| 03/02/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 11/02/2022 | Linus Health, Inc. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: DEVICE | ||||||
| 08/23/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.44 | General |
| 04/26/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/26/2021 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HBV | ||||||
| 12/03/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.76 | General |
| 10/01/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 08/26/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.33 | General |
| 08/25/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 05/02/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.77 | General |
| 04/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $103.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.21 | General |
| 02/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $71.14 | General |
| Category: HBV | ||||||
| 10/05/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.25 | General |
| 09/25/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 08/29/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: Endocrinology | ||||||
| 08/29/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 323 | 491 | $49,228 | $21,010 |
| 2022 | 11 | 424 | 655 | $71,313 | $34,286 |
| 2021 | 11 | 519 | 762 | $87,180 | $35,440 |
| 2020 | 13 | 841 | 1,118 | $136,162 | $46,990 |
Total Patients
2,107
Total Services
3,026
Medicare Billing
$137,726
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 191 | $29,098 | $12,506 | 43.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 26 | 58 | $5,800 | $1,851 | 31.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 39 | $3,900 | $1,779 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $2,150 | $1,536 | 71.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 43 | 43 | $2,580 | $941.70 | 36.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 24 | $1,200 | $830.88 | 69.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 12 | 12 | $1,800 | $603.36 | 33.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $1,000 | $430.40 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 45 | $900.00 | $378.00 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 16 | $800.00 | $152.94 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 225 | $35,383 | $17,288 | 48.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,800 | $3,893 | 81.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 38 | 89 | $8,040 | $3,561 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 35 | $7,650 | $3,273 | 42.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 44 | $5,320 | $2,023 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 48 | $2,400 | $1,702 | 70.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 49 | 49 | $2,940 | $1,033 | 35.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $800.00 | $567.72 | 71.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $950.00 | $424.96 | 44.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 68 | 93 | $1,880 | $275.76 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 23 | $1,150 | $244.37 | 21.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 188 | $33,840 | $15,024 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 72 | $18,000 | $7,349 | 40.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 72 | 174 | $13,920 | $6,306 | 45.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 43 | $6,450 | $2,051 | 31.8% |
About Dr. Bin Wang, MD
Dr. Bin Wang, MD is a Internal Medicine healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942335096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bin Wang, MD has received a total of $3,990 in payments from pharmaceutical and medical device companies, with $275.00 received in 2024. These payments were reported across 54 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,426).
As a Medicare-enrolled provider, Wang has provided services to 2,107 Medicare beneficiaries, totaling 3,026 services with total Medicare billing of $137,726. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Flushing, NY
- Active Since 02/22/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942335096
Products in Payments
- Vemlidy (Drug) $1,410
- XARELTO (Drug) $404.80
- INVOKANA (Drug) $182.02
- Vascepa (Drug) $150.28
- Otezla (Drug) $134.62
- Prolia (Biological) $114.58
- OFEV (Drug) $101.54
- FORTEO (Drug) $93.87
- iPro2 (Device) $90.00
- JANUMET (Drug) $89.04
- Tymlos (Biological) $41.69
- SPIRIVA (Drug) $15.33
- CORE COGNITIVE EVALUATION (Device) $13.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flushing
Calvin Pan, M.d, M.D
Internal Medicine — Payments: $975,186
Internal Medicine $975,186
Ari Bunim, Md, MD
Internal Medicine — Payments: $361,039
Internal Medicine $361,039
Glenn Turett, M.d, M.D
Internal Medicine — Payments: $231,558
Internal Medicine $231,558
Weining Liang, Md, MD
Internal Medicine — Payments: $180,077
Internal Medicine $180,077
Dr. Yong Yu, M.d, M.D
Internal Medicine — Payments: $144,144
Internal Medicine $144,144
Dr. John Sciales, M.d, M.D
Internal Medicine — Payments: $92,715
Internal Medicine $92,715